Location History:
- North Wales, PA (US) (2013)
- Philadelphia, PA (US) (2014)
- Doylestown, PA (US) (2013 - 2024)
Company Filing History:
24 out of 2,405 
6 out of 100 
1 out of 9 Years Active: 2013-2025
Title: Innovations by Izzat Tiedje Raheem in Central Nervous System Therapeutics
Introduction
Izzat Tiedje Raheem, an accomplished inventor based in Doylestown, PA, has made significant contributions to the field of pharmacology through his innovative patents. With a total of 24 patents to his name, Raheem has focused on developing therapeutic agents aimed at addressing central nervous system disorders.
Latest Patents
One of Raheem's notable recent inventions is the pro drugs of PDE10 compounds. This invention is directed toward pro drugs of 2-methyl-N-((5-methyl-1,3,4-thiadiazol-2-yl)methyl)-6-(((1S,2S)-2-(5-methylpyridin-2-yl)cyclopropyl)methoxy)pyrimidin-4-amine. These compounds have shown promise as therapeutic agents for the treatment of disorders associated with phosphodiesterase 10 (PDE10). Raheem's invention specifically targets neurological and psychiatric disorders, including schizophrenia, psychosis, and Huntington's disease, particularly those connected to striatal hypofunction or basal ganglia dysfunction.
Career Highlights
Raheem has built a successful career, notably working with prominent companies such as Merck Sharp & Dohme Corporation and Idenix Pharmaceuticals, Inc. His work at these organizations has enabled him to develop groundbreaking therapies that contribute significantly to advancing medical science in the realm of mental health and neurological care.
Collaborations
Throughout his career, Izzat Tiedje Raheem has collaborated with esteemed professionals, including John D. Schreier and Christopher D. Cox. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the potential impact of his innovations in the pharmaceutical landscape.
Conclusion
Izzat Tiedje Raheem's contributions to the field of therapeutic agents for central nervous system disorders have been remarkable. With a strong portfolio of 24 patents, his work not only reflects innovative thinking but also a commitment to improving the quality of life for individuals affected by neurological and psychiatric conditions. The advancements brought forth by Raheem continue to inspire further research and development in this vital area of medicine.